70% of WHO’s vaccines (as per the essential Immunization schedule) are sourced from India.ĭrugs and Pharmaceuticals shares 5.15% of the total exports of the country in the month of April. The Average Index of Industrial Production of Manufacturing of pharmaceuticals, medicinal chemicals and botanical products in the FY 2021-22 is 221.6 and has grown by 1.3 percent. Exports of Drugs & Pharmaceuticals values at USD 2067.63 mn in May 2022 and records positive growth vis-à-vis May 2021 of 10.28%. India also accounts for ~60% of global vaccine demand, and is a leading supplier of DPT, BCG and Measles vaccines. India supplies over 50% of Africa’s requirement for generics, ~40% of generic demand in the US and ~25% of all medicine in the UK. India is a major exporter of Pharmaceuticals, with over 200+ countries served by Indian pharma exports. The pharmaceutical industry in India is currently valued at $41.7 bn. Indian pharma companies enabled by their price competitiveness and good quality, have made global mark, with 60 per cent of the world’s vaccines and 20% of generic medicines coming from India.ġ00% Foreign Direct Investment (FDI) in the Pharmaceutical sector is allowed under the automatic route for greenfield pharmaceuticals.ġ00% FDI in the pharmaceutical sector is allowed in brownfield pharmaceuticals wherein 74% is allowed under the automatic route and thereafter through the government approval route.įor further details, please refer FDI Policy India is the 4th largest Asian medical devices market after Japan, China, and South Korea and among the top 20 global medical devices markets in the world. Cost of manufacturing ~ 33% lower than western markets.Incentives worth INR 21,940 Crore ($3 Mn) are approved.Major segments include generic drugs, OTC Medicines, API/Bulk Drugs, Vaccines, Contract Research & Manufacturing, Biosimilars and Biologics. The pharmaceutical industry in India offers 60,000 generic brands across 60 therapeutic categories. The nation is the largest provider of generic medicines globally, occupying a 20% share in global supply by volume, and is the leading vaccine manufacturer globally. India also has the highest number of US-FDA compliant Pharma plants outside of USA and is home to more than 3,000 pharma companies with a strong network of over 10,500 manufacturing facilities as well as a highly skilled resource pool. India ranks 3rd worldwide for production by volume and 14th by value.
The Indian Pharmaceuticals industry plays a prominent role in the global pharmaceuticals industry. If there are any concerns regarding the accuracy of the information presented within the translated versions of our site, please refer back to the official English language website. By using Google Translate, you understand and agree to this disclaimer. We shall not be liable for any inaccuracies or errors in the translation and shall not accept liability for any loss, damage, or other problem, including without limitation, indirect or consequential loss or damage arising from or in connection with use of the Google Translate Service. Viewers who rely on information through Google Translate on our website do so at their own risk. We can only verify the validity and accuracy of the information provided in English. We do not make any promises, assurances, or guarantees as to the accuracy, reliability, or timeliness of the translations provided. We do not own, manage or control any aspect of Google Translate and are not responsible for the translations provided by Google Translate. We provide this link to Google Translate as a courtesy to visitors. Please see our disclaimer at the bottom of this page. However, please be aware that, since translations are done by machine, they may not always be perfect. By providing these translations, we hope to make essential information available to a diverse range of investors. Google Translate – an automatic translation service that uses state-of-the-art technology, not human translators, to translate text – provides instant translations in different languages.
0 kommentar(er)
